Nevertheless, given the vast potential of siRNA as a therapy, this approach could pave the way for a new generation of treatments for numerous neurological diseases. Moreover, RVG–9R might not ...

Functional cure of chronic hepatitis B (CHB) remains a major clinical challenge. Current therapies—including nucleos(t)ide ...

today announced the publication of preclinical data in the journal Epilepsia demonstrating proof-of-mechanism of its investigational di-siRNA therapy, ATL-201, in a mouse model of KCNT1-related ...